Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1978 Dec;62(6):1187–1193. doi: 10.1172/JCI109238

Properties of endogenous somatostatin-like immunoreactivity and synthetic somatostatin in dog plasma.

J M Conlon, C B Srikant, E Ipp, V Schusdziarra, W Vale, R H Unger
PMCID: PMC371883  PMID: 748373

Abstract

Somatostatin-like immunoreactivity (SLI) in the peripheral venous plasma of dogs and in their pancreatic and gastric venous effluents was characterized and compared with synthetic somatostatin. Both endogenuous plasma SLI and somatostatin added to plasma were eluted from Sephadex gels at pH 8.8 in the 150,000--200,000-mol wt region but at pH 2.5 both appeared in the 1,500--2,000-mol wt region. The SLI released from the isolated dog pancreas perfused with plasma-free buffer was eluted entirely as a 1,600-dalton polypeptide, but when the pancreas was perfused with plasma, SLI was eluted in the 150,000--200,000-mol wt zone. Affinity chromatography of plasma samples on immobilized antibodies directed against the central portion of the somatostatin molecule (residues 5--9 and 11) removed approximately equal to 90% of both endogenous SLI and somatostatin added to plasma, but neither was removed by affinity chromatography on antibodies directed against the NH2-terminal region of somatostatin (residues 1--4). The SLI from plasma and from pancreas perfusate isolated by affinity chromatography was identical in molecular size, charge, and immunometric properties to synthetic somatostatin. It is concluded that endogenous SLI is secreted by the pancreas and stomach in a form not distinguishable from synthetic somatostatin, but circulates in plasma bound to large molecular weight components; the NH2-terminal residues of somatostatin appear to be important in this binding.

Full text

PDF
1187

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arimura A., Lundqvist G., Rothman J., Chang R., Fernandez-Durango R., Elde R., Coy D. H., Schally A. V., Meyers C. Radioimmunoassay of somatostatin. Metabolism. 1978 Sep;27(9 Suppl 1):1139–1144. doi: 10.1016/0026-0495(78)90032-x. [DOI] [PubMed] [Google Scholar]
  2. Arimura A., Sato H., Coy D. H., Schally A. V. Radioimmunoassay for GH-release inhibiting hormone. Proc Soc Exp Biol Med. 1975 Mar;148(3):784–789. doi: 10.3181/00379727-148-38631. [DOI] [PubMed] [Google Scholar]
  3. Arimura A., Sato H., Dupont A., Nishi N., Schally A. V. Somatostatin: abundance of immunoreactive hormone in rat stomach and pancreas. Science. 1975 Sep 19;189(4207):1007–1009. doi: 10.1126/science.56779. [DOI] [PubMed] [Google Scholar]
  4. Blackwell R., Vale W., Amoss M., Burgus R., Monahan M., Rivier J., Ling N., Guillemin R. Lack of effect of native or synthetic LRF on secretion of prolactin in vitro. Am J Physiol. 1973 Jan;224(1):176–179. doi: 10.1152/ajplegacy.1973.224.1.176. [DOI] [PubMed] [Google Scholar]
  5. Diel F., Schneider E., Quabbe H. J. Development of a radioimmunoassay for cyclic somatostatin: antibody production, comparative radioiodination, and dose-response curve. J Clin Chem Clin Biochem. 1977 Dec;15(12):669–677. doi: 10.1515/cclm.1977.15.1-12.669. [DOI] [PubMed] [Google Scholar]
  6. Dubois M. P. Immunoreactive somatostatin is present in discrete cells of the endocrine pancreas. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1340–1343. doi: 10.1073/pnas.72.4.1340. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Harris V., Conlon J. M., Srikant C. B., McCorkle K., Schusdziarra V., Ipp E., Unger R. H. Measurements of somatostatin-like immunoreactivity in plasma. Clin Chim Acta. 1978 Jul 15;87(2):275–283. doi: 10.1016/0009-8981(78)90348-0. [DOI] [PubMed] [Google Scholar]
  8. Hintz R. L., Liu F. Demonstration of specific plasma protein binding sites for somatomedin. J Clin Endocrinol Metab. 1977 Nov;45(5):988–995. doi: 10.1210/jcem-45-5-988. [DOI] [PubMed] [Google Scholar]
  9. Holladay L. A., Puett D. Somatostatin conformation: evidence for a stable intramolecular structure from circular dichroism, diffusion, and sedimentation equilibrium. Proc Natl Acad Sci U S A. 1976 Apr;73(4):1199–1202. doi: 10.1073/pnas.73.4.1199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hökfelt T., Efendić S., Hellerström C., Johansson O., Luft R., Arimura A. Cellular localization of somatostatin in endocrine-like cells and neurons of the rat with special references to the A1-cells of the pancreatic islets and to the hypothalamus. Acta Endocrinol Suppl (Copenh) 1975;200:5–41. [PubMed] [Google Scholar]
  11. Ipp E., Dobbs R. E., Arimura A., Vale W., Harris V., Unger R. H. Release of immunoreactive somatostatin from the pancreas in response to glucose, amino acids, pancreozymin-cholecystokinin, and tolbutamide. J Clin Invest. 1977 Sep;60(3):760–765. doi: 10.1172/JCI108829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ipp E., Dobbs R. E., Harris V., Arimura A., Vale W., Unger R. H. The effects of gastrin, gastric inhibitory polypeptide, secretin, and the octapeptide of cholecystokinin upon immunoreactive somatostatin release by the perfused canine pancreas. J Clin Invest. 1977 Nov;60(5):1216–1219. doi: 10.1172/JCI108875. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Iversen J., Miles D. W. Evidence for a feedback inhibition of insulin on insulin secretion in the isolated, perfused canine pancreas. Diabetes. 1971 Jan;20(1):1–9. doi: 10.2337/diab.20.1.1. [DOI] [PubMed] [Google Scholar]
  14. Kronheim S., Berelowitz M., Pimstone B. L. A radioimmunoassay for growth hormone release-inhibiting hormone: method and quantitative tissue distribution. Clin Endocrinol (Oxf) 1976 Nov;5(6):619–630. doi: 10.1111/j.1365-2265.1976.tb03865.x. [DOI] [PubMed] [Google Scholar]
  15. Kronheim S., Berelowitz M., Pimstone B. L. The characterization of somatostatin-like immunoreactivity in human serum. Diabetes. 1978 May;27(5):523–529. doi: 10.2337/diab.27.5.523. [DOI] [PubMed] [Google Scholar]
  16. Luft R., Efendic S., Hökfelt T., Johansson O., Arimura A. Immunohistochemical evidence for the localization of somatostatin--like immunoreactivity in a cell population of the pancreatic islets. Med Biol. 1974 Dec;52(6):428–430. [PubMed] [Google Scholar]
  17. Murphy R. F., Buchanan K. D., Elmore D. T. Isolation of glucagon-like immunoreactivity of gut by affinity chromatography on anti-glucagon antibodies coupled to sepharose 4 B. Biochim Biophys Acta. 1973 Mar 23;303(1):118–127. doi: 10.1016/0005-2795(73)90153-0. [DOI] [PubMed] [Google Scholar]
  18. Murphy R. F., Conlon J. M., Imam A., Kelly G. J. Comparison of non-biospecific effects in immunoaffinity chromatography using cyanogen bromide and bifunctional oxirane as immobilising agents. J Chromatogr. 1977 May 21;135(2):427–433. doi: 10.1016/s0021-9673(00)88384-3. [DOI] [PubMed] [Google Scholar]
  19. Nishikawa A. H., Bailon P. Affinity purification methods. Nonspecific adsorption of proteins due to ionic groups in cyanogen bromide treated agarose. Arch Biochem Biophys. 1975 Jun;168(2):576–584. doi: 10.1016/0003-9861(75)90289-1. [DOI] [PubMed] [Google Scholar]
  20. Ogawa N., Thompson T., Friesen H. G., Martin J. B., Brazeau P. Properties of soluble somatostatin-binding protein. Biochem J. 1977 Aug 1;165(2):269–277. doi: 10.1042/bj1650269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Orci L., Baetens D., Dubois M. P., Rufener C. Evidence for the D-cell of the pancreas secreting somatostatin. Horm Metab Res. 1975 Sep;7(5):400–402. doi: 10.1055/s-0028-1093736. [DOI] [PubMed] [Google Scholar]
  22. Patel Y. C., Reichlin S. Somatostatin in hypothalamus, extrahypothalamic brain, and peripheral tissues of the rat. Endocrinology. 1978 Feb;102(2):523–530. doi: 10.1210/endo-102-2-523. [DOI] [PubMed] [Google Scholar]
  23. Patton G. S., Ipp E., Dobbs R. E., Orci L., Vale W., Unger R. H. Pancreatic immunoreactive somatostatin release. Proc Natl Acad Sci U S A. 1977 May;74(5):2140–2143. doi: 10.1073/pnas.74.5.2140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Patton G. S., Ipp E., Dobbs R. E., Orci L., Vale W., Unger R. H. Response of pancreatic immunoreactive somatostatin to arginine. Life Sci. 1976 Dec 15;19(12):1957–1959. doi: 10.1016/0024-3205(76)90131-4. [DOI] [PubMed] [Google Scholar]
  25. Pelletier G., Leclerc R., Arimura A., Schally A. V. Letter: Immunohistochemical localization of somatostatin in the rat pancreas. J Histochem Cytochem. 1975 Sep;23(9):699–702. doi: 10.1177/23.9.1100709. [DOI] [PubMed] [Google Scholar]
  26. Polak J. M., Pearse A. G., Grimelius L., Bloom S. R. Growth-hormone release-inhibiting hormone in gastrointestinal and pancreatic D cells. Lancet. 1975 May 31;1(7918):1220–1222. doi: 10.1016/s0140-6736(75)92198-4. [DOI] [PubMed] [Google Scholar]
  27. Primstone B., Berelowitz M., Kranold D., Shapiro B., Kronheim S. Somatostatin-like immunoreactivity (SRIF-LI) in human and rat serum. Metabolism. 1978 Sep;27(9 Suppl 1):1145–1149. doi: 10.1016/0026-0495(78)90033-1. [DOI] [PubMed] [Google Scholar]
  28. Schally A. V., Dupont A., Arimura A., Redding T. W., Nishi N., Linthicum G. L., Schlesinger D. H. Isolation and structure of somatostatin from porcine hypothalami. Biochemistry. 1976 Feb 10;15(3):509–514. doi: 10.1021/bi00648a009. [DOI] [PubMed] [Google Scholar]
  29. Schauder P., McIntosh C., Arends J., Arnold R., Frerichs H., Creutzfeldt W. Somatostatin and insulin release from isolated rat pancreatic islets stimulated by glucose. FEBS Lett. 1976 Oct 1;68(2):225–227. doi: 10.1016/0014-5793(76)80441-3. [DOI] [PubMed] [Google Scholar]
  30. Schusdziarra V., Harris V., Conlon J. M., Arimura A., Unger R. Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog. J Clin Invest. 1978 Sep;62(3):509–518. doi: 10.1172/JCI109154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Srikant C. B., McCorkle K., Unger R. H. Properties of immunoreactive glucagon fractions of canine stomach and pancreas. J Biol Chem. 1977 Mar 25;252(6):1847–1851. [PubMed] [Google Scholar]
  32. Vale W., Ling N., Rivier J., Villarreal J., Rivier C., Douglas C., Brown M. Anatomic and phylogenetic distribution of somatostatin. Metabolism. 1976 Nov;25(11 Suppl 1):1491–1494. doi: 10.1016/s0026-0495(76)80175-8. [DOI] [PubMed] [Google Scholar]
  33. Vale W., Rivier J., Ling N., Brown M. Biologic and immunologic activities and applications of somatostatin analogs. Metabolism. 1978 Sep;27(9 Suppl 1):1391–1401. doi: 10.1016/0026-0495(78)90081-1. [DOI] [PubMed] [Google Scholar]
  34. Wilchek M., Miron T. On the mode of adsorption of proteins to "hydrophobic columns". Biochem Biophys Res Commun. 1976 Sep 7;72(1):108–113. doi: 10.1016/0006-291x(76)90967-0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES